NYSE: BNBrookfield Corp Stock
$51.00+0.95 (+1.9%)
Updated Apr 23, 2025
BN Price
$51.00
Fair Value Price
N/A
Market Cap
$83.94B
52 Week Low
$39.27
52 Week High
$62.78
P/E
164.52x
P/B
1.83x
P/S
1.01x
PEG
0.63x
Dividend Yield
0.33%
Revenue
$86.01B
Earnings
$641.00M
Gross Margin
21%
Operating Margin
21.21%
Profit Margin
0.7%
Debt to Equity
7.07
Operating Cash Flow
$8B
Beta
1.35
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A
BN Overview
Brookfield Asset Management Inc. is an alternative investment management companies. It focuses on direct control investments in real estate, renewable power, infrastructure, credit, and private equity. The company invests in distressed securities through Oaktree Capital, which it bought in 2019. Brookfield was founded in 1899 and is headquartered in Toronto, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Asset Management
Industry Rating
C
BN
Ranked#63 of 86
Ranked#63 of 86
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.48 | B | |
| $23.71 | B | |
| $15.00 | B |
Be the first to know about important BN news, forecast changes, insider trades & much more!
BN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BN ($51.00) is trading above its intrinsic value of $29.17, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BN is poor value based on its earnings relative to its share price (164.52x), compared to the US market average (26.95x)
P/E vs Market Valuation
BN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BN due diligence checks available for Premium users.
Valuation
BN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
164.52x
Industry
33.82x
Market
26.95x
BN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
BN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.83x
Industry
2.57x
BN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BN price to earnings growth (PEG)
For valuing profitable companies with growth potential
BN is good value based... subscribe to Premium to read more.
PEG Value Valuation
BN's financial health
Profit margin
Revenue
$19.4B
Net Income
$432.0M
Profit Margin
2.2%
BN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$490.4B
Liabilities
$325.0B
Debt to equity
7.07
BN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.2B
Investing
-$9.4B
Financing
$9.8B
BN vs Asset Management Stocks
Brookfield Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.